Dr. Min Wu's lab at Yale University explores how cell size impacts immune function and aging. They are particularly interested in how larger immune cells can still operate effectively without becoming senescent, which is a state of irreversible growth arrest often linked to aging. By studying pathways that regulate cell size, the lab aims to uncover new strategies to combat age-related immune dysfunction.

Dr. Ifat Levy's lab at Yale University focuses on understanding how the brain processes learning, decision-making, and memory, particularly in relation to anxiety and stress-related disorders. Through a combination of behavioral studies and advanced imaging techniques, the team aims to uncover the neural mechanisms behind these cognitive functions and how they vary among individuals. The ultimate goal is to inform tailored interventions that can better address mental health challenges.

Dr. Marcelo Dietrich's lab at Yale University studies how the early interactions between mothers and infants shape brain development and social behavior. They focus on understanding specific neuron types that influence these interactions and the impacts of early life adversity, like childhood maltreatment, on long-term mental health. By investigating these neural systems in mice, the lab aims to uncover insights that could enhance developmental outcomes and help address social and psychological disorders.

Dr. Shangqin Guo's lab focuses on understanding how certain proteins, known as linker histones, can influence the development of blood cells from their precursor cells. The research investigates how manipulating these proteins could lead to better outcomes in diseases like cancer and blood disorders by promoting the production of immune cells. The lab uses a variety of genetic models and inhibitors to explore these mechanisms at a molecular level, aiming to create new therapeutic strategies for treating hematological diseases.

Dr. Diane Krause's lab at Yale University focuses on understanding how specific blood cell types, like platelets and red blood cells, are formed from stem cells in the bone marrow. By studying a transcription factor called RUNX1, which is commonly mutated in leukemia, the lab aims to uncover the molecular mechanisms that dictate whether a cell becomes a platelet or a red blood cell. This research has important implications for developing new treatments for blood-related diseases.

Dr. Gisela Gabernet's lab at Yale University focuses on developing advanced computational tools for analyzing immune system data, particularly related to B cell and T cell responses. The lab works on processing high-throughput sequencing data to better understand immune reactions to infections and diseases, creating user-friendly software tools to help other researchers. By making data analysis easier and more accessible, the lab aims to enhance research in infectious diseases and immune-mediated conditions.

Dr. Christopher G. Burd's lab at Yale University focuses on understanding how lipids are distributed and modified in different parts of the cell, particularly in the Golgi apparatus. By studying these processes, the lab aims to uncover new insights into how cells regulate their internal environment, which can be crucial for understanding various diseases, including cancer and neurodegenerative disorders like Alzheimer's. The research has implications for improving our knowledge of cell function and potential therapeutic targets.

Dr. Kurt A Schalper's lab at Yale University focuses on studying the immune environment in lung cancer to improve diagnosis and treatment. We analyze how immune cells interact with tumors to better select which patients will benefit from immunotherapy. By investigating the characteristics of tumors and their surrounding immune cells, the research aims to develop more effective cancer treatments.

The Ferguson lab at Yale University focuses on understanding how lysosomes function in neurons, particularly in the context of Alzheimer's disease. They investigate the proteins JIP3 and JIP4, which play crucial roles in regulating lysosome movement and signaling within nerve cells. By uncovering the mechanisms that affect lysosome behavior, the lab aims to contribute to the development of therapeutic strategies for neurodegenerative diseases.

Dr. Karin M. Reinisch's lab at Yale University focuses on the molecular mechanisms behind how cells maintain and expand their membrane structures. The research emphasizes understanding how proteins facilitate the transfer of lipids between cellular organelles, a critical process for both cell function and the formation of new organelles, which has implications for understanding neurodegenerative diseases like Alzheimer's and Parkinson's.

Dr. Matthew Rodeheffer's lab at Yale University focuses on understanding the mechanisms behind obesity and its related diseases. The research particularly explores how the communication between endothelial cells and fat cells contributes to the accumulation and function of fat tissue. By studying hormones like estrogen and glucocorticoids in this context, the lab aims to develop new therapeutic strategies to combat obesity and associated metabolic disorders.

Dr. Yajaira Suarez's lab at Yale University studies how certain cellular processes in blood vessels and immune cells contribute to heart diseases, particularly atherosclerosis. They focus on understanding how non-coding RNAs and specific metabolic pathways influence the behavior of endothelial cells, smooth muscle cells, and macrophages in the context of vascular inflammation. The ultimate goal of this research is to uncover new treatment strategies for cardiovascular diseases through a better understanding of these mechanisms.

Dr. Joerg Bewersdorf's lab at Yale University focuses on advancing super-resolution microscopy techniques to better visualize the intricate structures of cellular organelles. The research aims to understand how these structures change in diseases like cancer and neurodegenerative disorders. By developing innovative imaging tools, the lab strives to make it easier for scientists to explore the complexities of cellular biology and to improve public health outcomes through better diagnostic and therapeutic strategies.

Dr. Yongli Zhang's lab at Yale University focuses on understanding how proteins involved in neuron communication and lipid transfer work at a molecular level. Specifically, the research explores how SNARE proteins help trigger the fusion of synaptic vesicles, which is essential for transmitting signals between nerve cells, and how lipid transfer proteins facilitate the movement of lipids between membranes. The ultimate goal is to uncover the mechanisms behind these processes, which could help in addressing various neurological diseases.

Dr. Vishwa Deep Dixit's lab focuses on understanding how aging and inflammation are linked to chronic diseases. By investigating the role of Fibroblast Growth Factor 21 (FGF21) and its receptor Klotho, the lab aims to uncover new strategies to enhance healthspan and lifespan by reducing age-related inflammation and metabolic dysfunction. The research includes exploring how FGF21 can be used therapeutically to combat the effects of aging.

Dr. Thomas James Melia's lab at Yale University focuses on understanding how cells deal with stress by creating autophagosomes, which are essential organelles that encapsulate and eliminate toxic components within the cell. His lab investigates the mechanisms by which cells harvest lipids necessary for autophagosome formation, especially under conditions of stress like disease or starvation. By elucidating these processes, the lab aims to provide insights into cell biology that could impact our understanding of various diseases such as infections, neurodegeneration, and cancer.

Dr. Carlos Fernandez Hernando's lab focuses on understanding how lipid metabolism affects immune responses in cardiovascular diseases, particularly atherosclerosis. They study novel enzymes and lipid molecules that help regulate inflammation and cholesterol levels in macrophages, which are immune cells involved in artery health. By investigating these pathways, the lab aims to uncover potential treatments that can improve cardiovascular health by targeting the underlying causes of inflammation and lipid imbalances.

Dr. Jeffrey R. Powell's lab at Yale University focuses on understanding the origins and genetic diversity of the Aedes aegypti mosquito, a key vector for serious human diseases like dengue and Zika. The lab conducts multidisciplinary research on populations from Indian Ocean islands, exploring how these ancestral mosquitoes are related to current populations worldwide and their potential role in disease transmission. Through techniques like genetics and virome analysis, the lab aims to discover new species and understand how these mosquitoes evolved to become effective carriers of viruses.

Dr. Sathish K. Ramakrishnan's lab at Yale University focuses on understanding how large dense-core vesicles (LDCVs) release important signals like hormones in our body. Their work explores how different types of vesicles behave differently during this release process, which is crucial for many functions such as metabolism and mood regulation. By using advanced technologies to observe and track these vesicles, the lab aims to uncover insights that could lead to better treatments for various diseases, including diabetes and mental health disorders.

Dr. Xiaoyong Yang's lab focuses on the role of a specific brain region, the ventromedial hypothalamus (VMH), in regulating body weight and metabolism. By studying the molecular mechanisms of O-GlcNAc transferase (OGT) in the VMH, the lab aims to understand how the brain senses nutrients and hormones to control energy balance and adipose tissue function. This research could lead to new therapies for obesity and related health issues.